Freenome

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.

Linus Health is a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. It brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. Linus Health's technology has been validated in over 20 published studies and is used by leading organizations to transform their approach to brain health.

Viz.ai is an AI-powered care coordination platform that helps providers improve patient outcomes. The platform uses advanced algorithms to analyze medical imaging data and provide real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions are used by hospitals and health systems across the country to improve care for patients with a variety of conditions, including stroke, heart disease, and cancer.

Lunit Inc. is a leading provider of AI-powered cancer screening and treatment solutions. The company's mission is to conquer cancer through AI by developing innovative technologies that can help detect and treat cancer earlier and more effectively. Lunit's AI solutions are used by hospitals and clinics around the world to improve the accuracy and efficiency of cancer diagnosis and treatment.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

Viz.ai is a leading provider of AI-powered care coordination solutions for healthcare providers. Its comprehensive platform leverages advanced algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions cover a wide range of therapeutic areas, including neurology, cardiology, vascular medicine, trauma, and radiology. The company's mission is to improve patient outcomes by closing the gaps between patients, clinicians, and life-saving treatments.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Proscia is a leading provider of digital pathology solutions for the modern laboratory. Its flagship product, Concentriq, is an enterprise pathology platform that enables anatomic pathology laboratories to achieve 100% digitization and deliver faster, more precise results. Proscia also offers a range of AI applications that can be used to automate tasks, improve diagnostic accuracy, and accelerate research. The company's mission is to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis - plaque build-up in the heart's arteries - not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes.

Butterfly iQ3 is a handheld, whole-body ultrasound device that provides clear and detailed images for a variety of medical applications. It is the third-generation probe from Butterfly Network, and it features double the processing power and clearer images than its predecessors. Butterfly iQ3 is also equipped with real-time AI, which can help clinicians to identify and diagnose medical conditions more quickly and accurately. The device is lightweight and portable, making it easy to use in a variety of settings, including the clinic, the hospital, and the field. Butterfly iQ3 is a valuable tool for clinicians who want to improve the quality of care they provide to their patients.

Limbic is a clinical AI application designed for mental healthcare providers to save time, improve outcomes, and maximize impact. It offers a suite of tools developed by a team of therapists, physicians, and PhDs in computational psychiatry. Limbic is known for its evidence-based approach, safety focus, and commitment to patient care. The application leverages AI technology to enhance various aspects of the mental health pathway, from assessments to therapeutic content delivery. With a strong emphasis on patient safety and clinical accuracy, Limbic aims to support clinicians in meeting the rising demand for mental health services while improving patient outcomes and preventing burnout.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover valuable insights. The platform is purpose-built for various conditions such as cancer, immune, endocrine, metabolic system, chronic diseases, aging, infectious diseases, and mental health, offering solutions for early biomarker discovery, drug repurposing, lead identification, compound optimization, trial monitoring, and response to treatment. JADBio is trusted by partners in precision health & medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

Regard is an AI-powered healthcare solution that automates clinical tasks, making it easier for clinicians to focus on patient care. It integrates with the EHR to analyze patient records and provide insights that can help improve diagnosis and treatment. Regard has been shown to improve hospital finances, patient safety, and physician happiness.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

SOMA is a Research Automation Platform that accelerates medical innovation by providing up to 100x speedup through process automation. The platform analyzes medical research articles, extracts important concepts, and identifies causal and associative relationships between them. It organizes this information into a specialized database forming a knowledge graph. Researchers can retrieve causal chains, access specific research articles, and perform tasks like concept analysis, drug repurposing, and target discovery. SOMA enhances literature review efficiency by finding relevant articles based on causal chains and keywords specified by the user. It empowers researchers to focus on their research by saving up to 95% of the time spent on pre-processing documents. The platform offers freemium access with extended functionality for 14 days and advanced features available through subscription.

Unlearn.ai is an AI-powered digital twins solution provider that optimizes clinical trials. Their TwinRCTs enable confident and quick clinical trials in various medical fields such as neuroscience, immunology, and metabolic diseases. By creating digital twins of patients, Unlearn.ai enhances the power and efficiency of clinical trials, attracting study participants and making confident decisions from early to late-stage studies.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

CompliantChatGPT is a HIPAA-compliant platform that allows users to utilize OpenAI's GPT models for healthcare-related tasks while maintaining data privacy and security. It anonymizes protected health information (PHI) by replacing it with tokens, ensuring compliance with HIPAA regulations. The platform offers various modes tailored to specific healthcare needs, including bloodwork analysis, PHI anonymization, diagnosis assistance, and treatment planning. CompliantChatGPT streamlines healthcare tasks, enhances productivity, and provides user-friendly assistance through its intuitive interface.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

Formula Wizard is an AI software designed to automate the process of writing Excel, Notion, and Airtable formulas. By leveraging artificial intelligence, users can save time and unlock insights from their data without the need for manual formula creation. The application simplifies the formula-writing process, allowing users to focus on their work while the AI handles the heavy lifting. With features such as automating tedious tasks, customizing templates, and running advanced calculations, Formula Wizard streamlines data analysis and enhances productivity.

Medallia is an AI-powered text analytics software that enables users to uncover high-impact insights and drive actions with real-time, human-centric text analytics. It offers comprehensive feedback capture, role-based reporting, AI & analytics, integrations, and enterprise-grade security. The platform helps organizations analyze unstructured data, derive hidden meanings behind words, create customizable KPIs, and build out-of-the-box topic models for various industries and use cases.

Luminal is a powerful AI copilot that helps users clean, transform, and analyze spreadsheets 10x faster. It offers fast and efficient data analysis capabilities, enabling users to perform complex operations and run AI-enabled tasks using natural language. With Luminal, users can visualize data, ask complex questions, and clean and format spreadsheets effortlessly. The application supports multiple languages, provides secure data hosting with encryption, and offers simple pricing that scales with user needs.

75 Wbet Com Daftar : OLX500 is an online platform offering a variety of casino games, including slots, live casino, poker, and more. Users can access popular games like Sweet Bonanza, Mahjong Ways, and Gates of Olympus. The platform also provides guidance on how to install the app on Android devices. With a focus on responsible gambling, 75 Wbet Com Daftar : OLX500 aims to enhance the gaming experience for its users.

NexusGPT is an AI tool that allows users to build and integrate custom AI agents to automate workflows without the need for coding. The platform offers a marketplace of tools and integrations, ready-made agents, and the ability to connect with various apps. Users can create autonomous agents that can complete complex tasks by planning and executing. NexusGPT aims to make agent creation, tailoring, and deployment as easy as possible, empowering users to enhance their agent's capabilities with a wide range of tools and AI models.

functime is a time-series machine learning tool designed to perform forecasting at scale. It provides a comprehensive set of functions and resources to assist users in analyzing and evaluating time-series data. With features like scoring, ranking, and plotting functions, functime aims to simplify the process of forecasting and make it accessible to users of all levels of expertise. The tool also offers an API reference for developers looking to integrate time-series forecasting capabilities into their applications.

Blobr is an AI tool designed to optimize ad spend effortlessly. It utilizes AI to analyze ad campaigns, ad copies, and performance to identify optimizations that save time and money. By continuously monitoring keywords, KPIs, and products, Blobr provides deep insights and correlations, suggesting improvements and new keywords. The tool helps in budget allocation, finding duplicates, recommending ad changes, and analyzing ad performance data. Blobr operates 24/7, offering proactive insights and recommendations to enhance ad campaigns and improve ROI.

Knowledgio is a no-code platform that allows users to easily build custom AI tools for agencies. It helps transform expertise into unique AI solutions, saving up to 70% of time with highly personalized tools. Users can create their AI workspace, embed knowledge without coding, share and monetize their tools, and collaborate in real-time with friends and coworkers. The platform offers an easy-to-use interface, dedicated support, automated distribution, and the ability to upload knowledge files and entities. Knowledgio aims to simplify the process of building AI tools and make it accessible even for non-technical users.

AIJ is an AI tool designed to streamline the job application process by automating tasks such as job search, application submission, and answering frequently asked questions. Users can save time and energy by letting AIJ handle these tasks efficiently. The tool also allows users to correct AI mistakes and save common questions for AI to answer. With pricing plans available, AIJ aims to simplify the job application process for users.

Fullpath is an AI-powered Customer Data Platform (CDP) designed specifically for auto dealerships. It helps dealers activate their data to create exceptional customer experiences through automated, AI-driven marketing campaigns. Fullpath integrates dealership-specific data sources, leverages AI technology for deep insights and personalized experiences, and ensures data security and compliance. The platform offers features like data connectivity, 360° shopper profiles, data activation, marketing automations, AI-driven insights, and sales enablement.

XenonStack is a Data and AI Foundry for Autonomous Operations, offering a platform for businesses to utilize data, accelerated computing, and software tools to simplify and scale enterprise and generative AI journeys. The platform provides services such as progressive delivery, real-time analytics, decision intelligence, technology consulting, and more. XenonStack focuses on empowering digital transformation with AI, big data, and cloud technologies to drive growth and excellence in various industries.